HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-22
DOI
10.1038/s41598-017-07787-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth
- (2016) Yu-Hung Huang et al. CANCER RESEARCH
- HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells
- (2016) C. Romeo et al. MOLECULAR CANCER RESEARCH
- IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells
- (2016) Janani Panneerselvam et al. Oncotarget
- HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy
- (2016) Meghna Mehta et al. Oncotarget
- Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis
- (2016) Fernando F. Blanco et al. Oncotarget
- Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells
- (2016) Akhil Srivastava et al. Scientific Reports
- Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration
- (2016) Ranganayaki Muralidharan et al. JOURNAL OF NANOBIOTECHNOLOGY
- Identification and Validation of Novel Small Molecule Disruptors of HuR-mRNA Interaction
- (2015) Xiaoqing Wu et al. ACS Chemical Biology
- HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer
- (2015) R Muralidharan et al. CANCER GENE THERAPY
- Technologies for controlled, local delivery of siRNA
- (2015) Samantha M. Sarett et al. JOURNAL OF CONTROLLED RELEASE
- Going beyond the liver: Progress and challenges of targeted delivery of siRNA therapeutics
- (2015) Cornelia Lorenzer et al. JOURNAL OF CONTROLLED RELEASE
- The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells
- (2015) F F Blanco et al. ONCOGENE
- mTOR-targeted therapy: Differential perturbation to mitochondrial membrane potential and permeability transition pore plays a role in therapeutic response
- (2014) Jae Eun Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chitosan Coated Polylactic Acid Nanoparticle-Mediated Combinatorial Delivery of Cisplatin and siRNA/Plasmid DNA Chemosensitizes Cisplatin-Resistant Human Ovarian Cancer Cells
- (2014) Anish Babu et al. MOLECULAR PHARMACEUTICS
- High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer
- (2013) Yasuyoshi Miyata et al. PLoS One
- Myostatin induces mitochondrial metabolic alteration and typical apoptosis in cancer cells
- (2013) Y Liu et al. Cell Death & Disease
- The Oncogenic RNA-Binding Protein Musashi1 Is Regulated by HuR via mRNA Translation and Stability in Glioblastoma Cells
- (2012) D. T. Vo et al. MOLECULAR CANCER RESEARCH
- HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium
- (2011) T Kurosu et al. BRITISH JOURNAL OF CANCER
- The RNA-Binding Protein HuR Promotes Glioma Growth and Treatment Resistance
- (2011) N. Filippova et al. MOLECULAR CANCER RESEARCH
- EGFR-Targeted Hybrid Plasmonic Magnetic Nanoparticles Synergistically Induce Autophagy and Apoptosis in Non-Small Cell Lung Cancer Cells
- (2011) Tomohisa Yokoyama et al. PLoS One
- The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer
- (2010) Robert Calaluce et al. BMC CANCER
- Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells
- (2010) Christine Hostetter et al. CANCER BIOLOGY & THERAPY
- Inhibitory effect of HuR gene small interfering RNA segment on laryngeal carcinoma Hep-2 cell growth
- (2010) Z Shen et al. JOURNAL OF LARYNGOLOGY AND OTOLOGY
- Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer
- (2010) Jun Wang et al. MEDICAL ONCOLOGY
- HuR Knockdown Changes the Oncogenic Potential of Oral Cancer Cells
- (2010) W. Kakuguchi et al. MOLECULAR CANCER RESEARCH
- RNA-binding protein HuR mediates cytoprotection through stimulation of XIAP translation
- (2010) D Durie et al. ONCOGENE
- pp32 (ANP32A) Expression Inhibits Pancreatic Cancer Cell Growth and Induces Gemcitabine Resistance by Disrupting HuR Binding to mRNAs
- (2010) Timothy K. Williams et al. PLoS One
- Regulation of Bcl-2 Expression by HuR in HL60 Leukemia Cells and A431 Carcinoma Cells
- (2009) D. Ishimaru et al. MOLECULAR CANCER RESEARCH
- Stabilization of XIAP mRNA through the RNA binding protein HuR regulated by cellular polyamines
- (2009) Xian Zhang et al. NUCLEIC ACIDS RESEARCH
- The Expression of RNA-Binding Protein HuR in Non-Small Cell Lung Cancer Correlates with Vascular Endothelial Growth Factor-C Expression and Lymph Node Metastasis
- (2009) Jun Wang et al. ONCOLOGY
- Expression of the embryonic lethal abnormal vision-like protein HuR in human mesothelioma
- (2008) Daniela Stoppoloni et al. CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started